HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
2023 · PLoS ONE · 9 citations
https://doi.org/10.1371/journal.pone.0285251
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
770
Citations
9
h-index
8
i10-index
Samar Alanazi is an academic researcher from King Saud bin Abdulaziz University for Health Sciences. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Melanoma and MAPK Pathways. The author has an h-index of 9, co-authored 26 publications.
ORCID: 0000-0002-2415-7227Click to start Chat